Financial & competing interests disclosure
The research to develop an improved MP-12 vaccine has been supported by the National Institute of Allergy and Infectious Diseases, NIH (R01 AI08764301 and 5 U54 AI057156) and Sealy Center for Vaccine Development at The University of Texas Medical Branch. In 2012, O Lihoradova was awarded the Maurice R Hilleman Early-Stage Career Investigator Award by the National Foundation for Infectious Diseases. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.